# Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors

> **NCT01148966** · PHASE1 · TERMINATED · sponsor: **University of Washington** · enrollment: 6 (actual)

## Conditions studied

- Adult Anaplastic Astrocytoma
- Adult Anaplastic Oligodendroglioma
- Adult Giant Cell Glioblastoma
- Adult Glioblastoma
- Adult Gliosarcoma
- Adult Mixed Glioma
- Recurrent Adult Brain Tumor

## Interventions

- **DRUG:** aminolevulinic acid
- **OTHER:** laboratory biomarker analysis
- **PROCEDURE:** therapeutic conventional surgery

## Key facts

- **NCT ID:** NCT01148966
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2012-04
- **Final completion:** —
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2017-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148966, "Aminolevulinic Acid During Surgery in Treating Patients With Malignant Brain Tumors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01148966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*